Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma × Patient Comfort × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Multidisciplinary Collaborative 1 Lymphoma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 24 Rituximab 16 fludarabine phosphate 13 Radiotherapy 12 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Filgrastim 10 Cytarabine 10 Methotrexate 9 Exercise 9 Doxorubicin 9 Cyclosporine 9 Busulfan 8 Antilymphocyte Serum 8 Mycophenolic Acid 7 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 6 Surveys and Questionnaires 6 Prednisone 6 Prednisolone 6 Methods 6 Etoposide 6 Educational Status 6 Early Intervention, Educational 6 Blood Specimen Collection 6 Palliative Care 5 Leucovorin 5 fludarabine 4 Geriatric Assessment 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡